Home Tests That Genome - Pharmacogenetics

That Genome - Pharmacogenetics

Umm Al Hamam Al Gharbi, Riyadh - 145KM

The Pharmaco Sensor is a cutting-edge pharmacogenetic test that helps patients and physicians understand how their genes influence drug response. By analyzing key genetic variations, this test reveals how an individual metabolizes, activates, or reacts to medications. With this knowledge, healthcare providers can personalize treatments, minimize side effects, and improve therapeutic outcomes.

Benefits:
Personalized Medicine: Ensures each patient receives the right medication at the right dose.
Reduced Side Effects
Faster Recovery: Avoids trial-and-error in prescribing by guiding physicians with precise data.
Optimized Treatment: Improves drug efficacy by tailoring medication choices.
Preventive Value: Detects enzyme deficiencies or variations before long-term drug complications occur.

Added Value:
Comprehensive Genetic Coverage: Includes analysis of major pharmacogenetic markers (CYP450 family, DPYD, TPMT, UGT1A1, SLCO1B1, VKORC1, NAT2, and more)

PHARMACO SENSOR:
Evidence-Based Recommendations: Based on international clinical guidelines (CPIC, DPWG, CPNDS, PharmGKB).
Broad Medication Database: Evaluates both commonly prescribed and specialty drugs across multiple therapeutic areas.
Physician Support: Report includes clear recommendations on effect, breakdown, and dose adjustments.
Patient-Centric: Easy-to-read summaries for patients, with detailed medical insights for doctors.

Recommendations:
Physicians should use Pharmaco Sensor results as part of the clinical decision-making process.
Drug changes should never be made by the patient without consulting a doctor.

The report highlights medications that may require:
Dose adjustment (lower or higher than standard)
Alternative drug selection if metabolism is severely impaired
More frequent monitoring for drugs with narrow therapeutic ranges (e.g., warfarin, phenytoin).

Total Number of Medications Covered:
The Pharmaco Sensor test evaluates over 2,300 FDA-approved medications

PHARMACO SENSOR, across multiple disease categories including:

Cardiology (e.g., warfarin, simvastatin, metoprolol)
Oncology (e.g., tamoxifen, capecitabine, fluorouracil, irinotecan)
Neurology/Psychiatry (e.g., antidepressants, antipsychotics, antiepileptics)
Pain Management (e.g., codeine, tramadol, oxycodone)
Gastroenterology (e.g., proton pump inhibitors, antiemetics)
Infectious Diseases (e.g., antivirals, antibiotics)
Others across digestion, metabolism, and movement disorders.

This makes it one of the most comprehensive pharmacogenetic panels available globally.